About ARRHYTHMIA.FINANCE

Our Story

ARRHYTHMIA.FINANCE was founded to bridge a critical gap in the cardiac device industry: the lack of a centralized platform for transaction intelligence, IP licensing, and professional services. As the financial vertical of the ArrHub Network, we combine 30 years of patent licensing expertise from Dalimer Legal with comprehensive market intelligence to serve the global arrhythmia industry.

Our platform tracks over 180 transactions from 2020-2024, connects 710+ verified professionals across 6 specialized networks, and provides the only dedicated IP licensing marketplace for arrhythmia technologies. We serve medical device executives, investors, patent holders, and service providers with the strategic intelligence they need to make informed decisions.

Built on the foundation of Dalimer Legal's three decades of successful patent licensing deals with companies like Medtronic, Abbott, and Boston Scientific, ARRHYTHMIA.FINANCE brings institutional-grade financial intelligence to the arrhythmia industry. Our Hexa-Network of attorneys, accountants, consultants, fundraising partners, patent agents, and marketing agencies provides comprehensive support for every stage of business growth and transition.

As part of the 46-domain ArrHub ecosystem, ARRHYTHMIA.FINANCE is positioned at the intersection of technology, finance, and healthcare innovation. We are committed to connecting capital with innovation and facilitating the transactions that advance cardiac care worldwide.